Pazopanib as a second-line treatment for non-cytokine-treated metastatic renal cell carcinoma: a meta-analysis of the effect of treatment.
about
Pazopanib as a second-line treatment for non-cytokine-treated metastatic renal cell carcinoma: a meta-analysis of the effect of treatment.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pazopanib as a second-line tre ...... is of the effect of treatment.
@ast
Pazopanib as a second-line tre ...... is of the effect of treatment.
@en
type
label
Pazopanib as a second-line tre ...... is of the effect of treatment.
@ast
Pazopanib as a second-line tre ...... is of the effect of treatment.
@en
prefLabel
Pazopanib as a second-line tre ...... is of the effect of treatment.
@ast
Pazopanib as a second-line tre ...... is of the effect of treatment.
@en
P2860
P921
P1433
P1476
Pazopanib as a second-line tre ...... sis of the effect of treatment
@en
P2093
Jung-Tsung Kuo
P2860
P356
10.1186/S12894-016-0156-4
P5008
P577
2016-07-04T00:00:00Z